Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
Clinical trial NCT05007938 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05007938
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-12
- Primary completion
- 2024-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.